Operator Good day, everyone and welcome to Pfizer's fourth-quarter 2024 earnings conference call. Today's call is being ...

Q4 2024 Earnings Conference Call February 4, 2025 10:30 AM ETCompany ParticipantsFrancesca DeMartino - Senior Vice President, ...

The results could sway U.S. regulators to convert Braftovi’s accelerated clearance in colorectal tumors into a full approval ...

Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk ...

Alarmed by the color and frequency of the blood in her stool, Mahon was referred to a GI doctor who initially thought she had an autoimmune disease. “Once I got the colonoscopy, she told me that she ...

Peakstock - stock.adobe.com A new DNA test developed in the UK can accurately predict whether high-risk patients will develop colorectal cancer in ... care for them, the best possible information ...

Pfizer's Braftovi combination showed significant survival benefits in a Phase 3 study for BRAF V600E-mutant metastatic ...

Jan. 28, 2025 — A data analysis from a randomized clinical trial for stage 3 colon cancer patients found that patients with evidence of residual cancer in their blood after surgery to remove the ...

Scientists discover that the CD74 protein could predict the effectiveness of immunotherapy, advancing colon cancer treatment.

Can a high-protein Italian cheese really decrease your risk of colorectal cancer? In an exclusive interview, an expert talks ...

A promising experimental blood test has shown the ability to accurately detect colon cancer with 81% accuracy in patients and correctly rule it out in 90% of healthy individuals. This less ...

Jan. 28, 2025 — A data analysis from a randomized clinical trial for stage 3 colon cancer patients found that patients with evidence of residual cancer in their ... Researchers Pioneer DNA ...